Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yassi Fallah

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biomarkers in Medicine|March 27, 2018
BP1, a potential biomarker for breast cancer prognosisYaoxian Lou, Yassi Fallah, Kellie Yamane, et al.
Biomolecules|July 12, 2017
MYC-Driven Pathways in Breast Cancer SubtypesYassi Fallah, Janetta Brundage, Paul Allegakoen, et al.
Frontiers in Oncology|July 19, 2021
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 InhibitorsYassi Fallah, Diane M Demas, Lu Jin, et al.
Cancers|September 19, 2020
Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast CancerSuzanne Bakewell, Isabel Conde, Yassi Fallah, et al.
Frontiers in Oncology|August 21, 2019
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast CancerDiane M Demas, Susan Demo, Yassi Fallah, et al.
Oncotarget|October 6, 2017
Metabolomic biomarkers of pancreatic cancer: a meta-analysis studyKhyati Y Mehta, Hung-Jen Wu, Smrithi S Menon, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biomarkers in Medicine|March 27, 2018
BP1, a potential biomarker for breast cancer prognosisYaoxian Lou, Yassi Fallah, Kellie Yamane, et al.
Biomolecules|July 12, 2017
MYC-Driven Pathways in Breast Cancer SubtypesYassi Fallah, Janetta Brundage, Paul Allegakoen, et al.
Frontiers in Oncology|July 19, 2021
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 InhibitorsYassi Fallah, Diane M Demas, Lu Jin, et al.
Cancers|September 19, 2020
Inhibition of DNA Repair Pathways and Induction of ROS Are Potential Mechanisms of Action of the Small Molecule Inhibitor BOLD-100 in Breast CancerSuzanne Bakewell, Isabel Conde, Yassi Fallah, et al.
Frontiers in Oncology|August 21, 2019
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast CancerDiane M Demas, Susan Demo, Yassi Fallah, et al.
Oncotarget|October 6, 2017
Metabolomic biomarkers of pancreatic cancer: a meta-analysis studyKhyati Y Mehta, Hung-Jen Wu, Smrithi S Menon, et al.
Pageof 1